Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get patent/product expiration details and freedom-to-operate opportunities
— API development, India
To know patent expiration dates for different drugs
— Physician, Hungary
To study patents on drugs in selected therapeutic areas
— Pharmaceutical process development, India
To checking the status of drug patents
— Market research, Vietnam
To perform literature and patent searches
— Life science entrepreneur, USA
Generated: May 24, 2017
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Technologies | XULANE | ethinyl estradiol; norelgestromin | FILM, EXTENDED RELEASE;TRANSDERMAL | 200910-001 | Apr 16, 2014 | AB | RX | No | Yes | ► Subscribe | ► Subscribe | ||||||||||||||||||
Bayer Hlthcare | SKYLA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 203159-001 | Jan 9, 2013 | RX | Yes | Yes | 9,615,965 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Bayer Hlthcare | SKYLA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 203159-001 | Jan 9, 2013 | RX | Yes | Yes | 7,252,839 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Pharmacia And Upjohn | PROVERA | medroxyprogesterone acetate | TABLET;ORAL | 011839-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Pharmacia And Upjohn | PROVERA | medroxyprogesterone acetate | TABLET;ORAL | 011839-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To get information on international drug patents
— Patent agent, USA
To update my knowledge in several markets
— Marketing professional, Spain
For drug patent information
— Pharmaceutical business developer, USA
To obtain a list of all currently off-patent approved small molecule therapeutics or those that will come off patent in the next 5 years
— Licensing / business development, Saudi Arabia
To be able to inform my clients with Part D prescription plans when a brand name drug is going off patent
— Pharmacist, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
